BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17459720)

  • 21. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
    Kim MJ; Lee JY; Lee SJ
    Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro inhibitory effect of dibenzoxanthene CY-B12 on proliferation of tumor cell lines and its possible mechanisms].
    Pu XX; Jiang GF; Chen Y; Xu ZL; Xian LJ
    Ai Zheng; 2005 Dec; 24(12):1442-7. PubMed ID: 16351789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
    Rooney RJ
    Cell Growth Differ; 2001 Oct; 12(10):505-16. PubMed ID: 11682462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin C transiently arrests cancer cell cycle progression in S phase and G2/M boundary by modulating the kinetics of activation and the subcellular localization of Cdc25C phosphatase.
    Thomas CG; Vezyraki PE; Kalfakakou VP; Evangelou AM
    J Cell Physiol; 2005 Nov; 205(2):310-8. PubMed ID: 15887239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian G1 and G2 phase checkpoints.
    O'Connor PM
    Cancer Surv; 1997; 29():151-82. PubMed ID: 9338101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines.
    García-Morales P; Carrasco-García E; Ruiz-Rico P; Martínez-Mira R; Menéndez-Gutiérrez MP; Ferragut JA; Saceda M; Martínez-Lacaci I
    Oncogene; 2007 Nov; 26(51):7185-93. PubMed ID: 17525741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation.
    Bahassi el M; Hennigan RF; Myer DL; Stambrook PJ
    Oncogene; 2004 Apr; 23(15):2658-63. PubMed ID: 14968113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
    Clemens DL; Calisto LE; Sorrell MF; Tuma DJ
    Hepatology; 2003 Aug; 38(2):385-93. PubMed ID: 12883482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of a soluble cyclin B/cdc2 substrate for cdc25 phosphatase.
    Clark JM; Gabrielli BG
    Anal Biochem; 1997 Dec; 254(2):231-5. PubMed ID: 9417782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.
    Aytac U; Claret FX; Ho L; Sato K; Ohnuma K; Mills GB; Cabanillas F; Morimoto C; Dang NH
    Cancer Res; 2001 Oct; 61(19):7204-10. PubMed ID: 11585756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells.
    Pang LP; Huang W; Sun Q; Guo W; Li RT; Cui JR
    Anticancer Drugs; 2008 Feb; 19(2):167-74. PubMed ID: 18176113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells.
    Dagon Y; Dovrat S; Vilchik S; Hacohen D; Shlomo G; Sredni B; Salzberg S; Nir U
    Oncogene; 2001 Dec; 20(56):8045-56. PubMed ID: 11781817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.
    Goldstone S; Pavey S; Forrest A; Sinnamon J; Gabrielli B
    Oncogene; 2001 Feb; 20(8):921-32. PubMed ID: 11314027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells.
    Ou TT; Wang CJ; Lee YS; Wu CH; Lee HJ
    Mol Nutr Food Res; 2010 Dec; 54(12):1781-90. PubMed ID: 20564478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.
    Dash BC; El-Deiry WS
    Mol Cell Biol; 2005 Apr; 25(8):3364-87. PubMed ID: 15798220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
    Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
    Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
    Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
    Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of CDC2/Cyclin B1 in response to selenium-induced oxidative stress during spermatogenesis: potential role of Cdc25c and p21.
    Kaushal N; Bansal MP
    Mol Cell Biochem; 2007 Apr; 298(1-2):139-50. PubMed ID: 17160696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
    Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
    Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.